Sanofi SA vs Tenet Healthcare Corporation — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Tenet Healthcare Corporation trades at $196.03 (market cap $16.74B). The key difference: Sanofi SA is far larger — about 6.3× Tenet Healthcare Corporation's market cap, and Sanofi SA pays a 5.5% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| SNY | THC | |
|---|---|---|
Market Cap | $104.83B | $16.74B |
Sector | Health | Health |
52-Week High | $52.34 | $244.80 |
52-Week Low | $41.33 | $148.38 |
Enterprise Value | $121.32B | $26.99B |
Dividend Yield | 5.5% | — |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →